chrisvoncsefalvay/vaers-outcomes huggingface dataset:
trouble lifting my arm; Pain in arm; Nauseous; Chills; Urge to cry; This is a spontaneous report from a contactable consumer who reported for herself . This 41-years-old no pregnant female patient received first dose of  bnt162b2 (BNT162B2)  from LOT# E19262, on  03Feb2021 17:30 on right arm at SINGLE DOSE for covid-19 immunisation .Age at vaccination:41 years. The patient didn't  receive any other vaccines within 4 weeks prior to the COVID vaccine . The patient received other medications within 2 weeks of vaccination .Medical history included :Allergy to adhesive, ADHD, high blood pressure (HBP), depression, anxiety, gerd. On 04Feb2021 20:00 the patient experienced chills, urge to cry, trouble lifting in arm , pain in arm and she was Nauseous. Events reported as non serious .No treatment received. Outcome was not recovered. Prior to vaccination  the patient was not  diagnosed with COVID-19Since the vaccination, the patient has not  been tested for COVID-19
I did NOT receive the shot. My husband did, and we were intimate that night and the night after. On day 3 after HIS shot, I had body aches, chills and malaise. When my period came (on time, 11 days after his shot), it's the heaviest it's ever been, even after each of my 4 births. It's an extremely heavy flow with lots of cervical fluid and tissue, as well as large clots. I've used the sympto-thermal method of birth control (checking temperature, cervical fluid, cervical position every day) for 18 years, and this is absolutely abnormal for me.
She got her two vaccines, sister is reporting it.  She lives next door to her brother, he went to check on her and she was slurring her words and he could not understand her and was just sitting in her chair.  He offered to get her something to eat and said that she was fixing something.  He said that she seemed to walk okay and had his wife go and look at her.  She went and said that she had a stroke and she was admitted to the hospital.  The stroke showed up on her CAT scan and then after she was there a couple of days she had a heart attack.  She has been home 6 days now and she is doing much better.    She was first admitted to a local Hospital on 9/16/22; she was then transferred to another Hospital where she was in the heart hospital, and then she went to a swing bed unit in a different HCF on 9/26/22.  She came back home on 10/11/22.  She is deaf and her hearing aides are not working so she probably would not answer the phone.  Her sister in law contact info is reported.
On 11/22/00 at 8:00 PM, the pt experienced slight redness at the injection site. The pt also complained of pain, warmth and the site was hard to the touch. A physician was consulted and the pt was prescribed moist compresses and diphenhydramine hydrochloride every four hours as needed. Subsequently, the pt recovered. No additional information is expected.
Upon receiving the vaccine I incurred a dizziness for 2 hrs (moderate intensity).  After a total of 4 hours the dizziness subsided.  No after effects.
This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 01/08/2021 and 01/29/2021. This was a re-infection, the individual having also tested positive for COVID-19 back on 10/24/2021 (which was also a breakthrough infection). The individual was hospitalized 12/19/2021-12/30/2021 for seemingly something other than COVID-19 and were discharged to hospice care at a rehabilitation center, where they tested positive upon intake (on 12/30/2021). The individual died on 01/04/2022.
Patient was sent to hospital because of change in mental status.  The pt was admitted to the hospital on  12/15/2021 because of acute encephalopathy due to COVID-19 cystitis.  IV ceftriaxone was continued.  IV steroids continued.  Patient also had seizure activity.  Patient was transferred to ICU.  MRI showed acute infarction left MCA distribution.  The patient was transferred to floor.  Patient also completed Remdesivir.  Patient oxygen requirement increased.  CTA chest showed pulmonary embolism.  Patient also developed acute renal failure and nephrology was consulted.  Kidney function worsening.  Patient family agreed with hospice.  Will discharge patient to nursing home with hospice
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported  Treatment information was not reported   This case was linked to MOD-2021-395985 (Patient Link).
Mother reports onset of significant fever and body aches. Reported temp max 103r in the 48 hours post vaccination, persisted temp over 101 for 96 hours and body aches for same. Mother declined office evaluation for event.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 29Sep2023 at 13:00 as dose 1, single (Lot number: 309) at the age of 58 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from 02Oct2023 to 06Oct2023.  No follow-up attempts are possible. No further information is expected.
Armpit pain; Hot to touch; large red looking welt approx 4-5 inches width; swollen lymph nodes armpit; swollen lymph nodes at site of injection; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 10:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient medical history included diabetes. Patient received other medication in 2 weeks which included dulaglutide (TRULICITY) for unknown indication and start date. The patient did not report any allergy to food, medication and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, 16 hours after 2nd vaccine, the patient woke at night with armpit pain, swollen lymph nodes armpit and at site of injection, hot to touch with large red-looking welt approx. 4-5 inches width. Three days later, still swollen at site, warm to touch with welt look and slight expansion of redness area. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/ department or urgent care. The clinical outcomes of the events armpit pain, hot to touch, large red-looking welt approx. 4-5 inches width, swollen lymph nodes armpit, swollen lymph nodes at site of injection were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
pt recvd vax; devel a three inch by five inch area of inflammation & swelling at inject site; sxs persisted for 2 days & the resolved
RECEIVED 2 SHINGRIXS 1 MONTH APART AS SUPPOSED TO AT LEAST 2 MONTHS APART
DEVELOPD PNEUMONIA 11 DAYS AFTEER REEIVING FIR DOSE OF PFIZER VACCINE
It was reported that a 39 year old female patient received a Fluzone SV vaccination on 12/04/2000. Sometime after the vaccination the patient developed a local reaction, 4cm red, swollen tender area at the injection site which lasted for 3 days.
Severe stomach cramps, nausea, diarrhea, vomiting, passed out, disoriented.
4-10-11 I had nausea for (6 to 7) days feeling fine now.
Headache, Myalgia, Fever, FATIGUE/INJECTION SITE PAIN AND SWELLING Narrative:
Myalgias started around 8:30pm the same day (9/11/21) as administration of the flu vaccine.  Low grade fever started around 9:30pm.  Tylenol was taken around 9:30pm before going to bed, then I woke up with fever of 102 degrees F around 11:20pm.   I also have a tender lump on the medial aspect of my left elbow (same arm as administration of the vaccine) with pain radiating about half way up my arm.   Injection site is sore and warm to touch with no surrounding erythema.  Fever subsided upon awakening this morning at 7:00am.  I continue to have mild myalgias and tenderness and lump in by inner elbow have not changed.
Pt called on 9/29  the morning after getting her PPSV23 to report she could not brush her hair or lift anything with that arm. She reports the pain was so severe she could not lie on that side when in bed. She denied any redness warmth or swelling at injection site. Instructed pt to take 400mg of ibuprofen every 6 hrs for 24 hrs and apply heat. The pt called back on 9/30/20 to report the following night she was able to sleep better but could not lie on her left side but was able to sleep on her back. She can lift her shoulder some now but continues to have severe pain. She reports the pain is above the site of injection and hurts in the shoulder not the muschle Instructed pt that any secondary effects of the vaccine should not get any worse after 72 hrs and should be improving. She continues to deny any redness warmth or swelling but did ask that she continue to take the ibuprofen every 6 hrs and take a dose of Benadryl tonight to assist with possible excessive  histamine response and to help her get some sleep. and to apply ice and alternate with heat. Advised pt that this RN would contact her in the AM to see if improved.
INCORRECT PRODUCT STORAGE; VACCINE WAS INJECTED DIRECTLY FROM THE FREEZER INTO THE PATIENT WITHOUT THE VACCINE BEING STORED AT RECOMMENDED STORAGE CONDITIONS OF 2 TO 8 CELSIUS; This spontaneous report received from a health care professional concerned a 47 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, expiry: UNKNOWN) dose was not reported, administered on 01-APR-2022 for prophylactic vaccination. Age at time of vaccination 47 years old. No concomitant medications were reported. On 01-APR-2022, the patient experienced vaccine was injected directly from the freezer into the patient without the vaccine being stored at recommended storage conditions of 2 to 8 celsius. On an unspecified date, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine was injected directly from the freezer into the patient without the vaccine being stored at recommended storage conditions of 2 to 8 celsius and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20220505340, 20220505162, 20220504995, 20220505192, 20220505593, 20220505824 and 20220505373.
Vaccine administered 10/15/12. Patient has been experiencing pain in arm (Left arm) that is worsening. Painful to lift arm. Pain not relieved w/ APAP or Ibuprofen.
- Pt recieved second Pfizer vaccine 5/4 - Developed chest pain on 5/13/21 without shortness of breath. Mother passed away 3 weeks ago and she is also anxious.  - Chest pain was severe enough to interfere with her leaving the house. Taking a deep breath made pain worse. Hunching over made her pain less severe. Took GABA supplement and felt better. Pain was worse with getting her daughter dressed. No personal or family history of heart disease. Chest is tender to touch.  - Chest pain eventually resolved. - Pt passed kidney stone 5/15/21
Pt got DTaP yesterday and Hep A today with left arm erythema and swelling at site. 4cmx5cm, warm. DTaP reaction reported. If worse tomorrow come to clinic. Rx: Administer ice. No more DTaP or hep A.
10.7.08 RECIEVED PNEUMOCOCCAL VACCINE; NEXT DAY HAD SORENESS AT SITE OF INJECTION. WORSENED AND WAS SENT TO EMERGENCY ROOM - DIAGNOSED CELLULITIS. TREATED WITH ROCEPHIN; RX KEFLEX. SAW DR. 10.13.08 AND IT WAS IMPROVED.
This minor reaction will not prevent me from going through with my second shot. I experienced pain at the injection site for about 27 hours. I also experienced nausea and vomiting the day after my injection for about 2 hours. I stayed hydrated and drank lots of chicken broth. After those few hours of nausea and vomiting, I felt perfectly fine and still feel perfectly fine.
This spontaneous report was received from a medical assistant concerning a male patient of unknown age who on 21-JUN-2012 was vaccinated with the first dose of PNEUMOVAX 23 (dose/frequency, route and lot # not provided). On 16-APR-2013, the patient received a second dose of PNEUMOVAX 23 (dose/frequency, route and lot # not provided). No adverse effects were reported. Additional information has been requested.
03/14/2022 I experienced chills during the night. By morning, I had a low-grade fever and a feeling of tiredness and listless. I tested positive for COVID-19 3/15/2022. The low grade fever last for 2-3 days and I just felt tired.
Vomiting, change in mental status, thickened terminal ileum and lymph nodes.
without any residual effects experienced by the consumer; inadvertently administered 2 Pneumovax23 vaccines; This spontaneous report was received from a 67 year old patient reporting on her/him self. No information was given regarding the patient's concurrent conditions, concomitant medication or medical history.  On 09-JUN-2020 the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # T007790 for prophylaxis. On 05-OCT-2020, the patient was inadvertently administered a second dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) without any residual effects experienced. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T007790; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
After receiving the vaccination, the employee began experiencing symptoms the same day. Employee reports experiencing a raised knot and rash on his arm. Employee reported itching, rash, headaches, joint pain from head to toe. Employee reports seeing a HCP at employee health regarding the rash but I was unable to find documentation of the visit. Employee reports telling his provider about his symptoms on 6/28/2022, and was told these symptoms were normal. Employee reported to Employee Health today to receive second set of vaccinations but is concerned about his continued symptoms. Employee reports joint pain from head to toe and feels like he could "pop all his joints." Employee reports that he cannot tolerate the earloops on his surgical mask, states that it causes pain on the back of his head. Employee reports if he were to wear a hat, it would give him what feels like the worst migraine ever. These symptoms started after his vaccinations. Employee has been taking benadryl, tylenol, and aleeve to help with symptoms. Employee rates pain at an 8 currently, despite taking his normal medications.
Had a moderately severe local reaction 24 hours after the vaccine was administered.  Has had recurrent urticarial rash at the site of vaccination since that time.  Last occured 4/11/03.
.8 ml vaccine administered by vaccinating nurse.  Further Education provided regarding recommended dose. Clinician states that the just in time training that was provided information that .8 ml was the recommended dose. Client made aware of the error; medical provider onsite assess client immediately post and again after 45 min observation time prior to discharge from  clinic site. no signs or symptoms of adverse reaction observed by RN or reported by client. Client aware that state immunization branch has been notified and that adverse event reports will be filed at both Pfizer website and on federal VAERS website.
No adverse effects reported.; was administered an improperly stored dose of PROQUAD; Information has been received from a nurse referring to an unknown gender patient of unknown age. The patient's historical condition and drug reactions or allergies were not reported. Concomitant therapies included sterile diluent.  On 12-NOV-2019, the patient was administered an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD)(lot # S012470, expiration date:20-OCT-2020, dose, frequency and route were not reported) for prophylaxis. The measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) experienced a temperature excursion at  -9°C to 8°C (0.9C) for 6 hours and 1 min; No previous temperature excursions. The temperature excursions were detected by a data logger. (Product storage error). No adverse effects were reported.
High/Drunk feeling  within 1 hour of shot, Not able to sleep at night for first 72 hours (2 hrs 1st night, 4 hours 2nd night, 4 hours 3rd night),  Very low mood and wishes I would die on 4/15 morning as pain/discomfort was so great. Severe Chills (shaking, needed 3 blanket) from late afternoon to early morning hours during the 1st 72 hr post injection, Severe night sweats 1st 3 nights - body was soaking wet and soaked through pajamas, Joint and muscle pain in arms, legs, face/jaw starting the 1st night after injection and continuing for 4 days after injection, Swollen, painful lymph nodes in under arm/neck - continues to this day (started night 1 and now 9 days after injection), Occasional dizziness when standing and sitting starting 4 days after injection and continuing for 48 hours, Blurred vision, people looks like they were swaying starting day 5 through day 6, Very Heavy vaginal bleeding started on day 7 (4/20), got worse on day 8 (4/21), and the same on day 9 (4/22): soaking through pad every 2-3 hours on day 8 and day 9.  bleeding continues at time of this report.  NOT like a period, or timing of my period.  My period is not due to start until 4/25 and I have been regular my entire life - 36 years! Cough and left arm pain started on day 8 (4/21) - I went to ER after calling my OBGYN and talking with the nurse.   NEVER had a fever, NEVER had cramps.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unkown date the patients were vaccinated with RECOMBIVAX HB. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. The nurse reported that multiple unspecified patients received RECOMBIVAX HB that was stored improperly. No adverse effects reported. Additional information is not expected.
hit the timer on my watch when the injection was given. By minute 2 my body was hot and my throat was starting to swell. Used Epi pen #1 .  I did not get better. I felt even more on fire and my skin was hot to the touch. My tongue was really swollen and things get super fuzzy after the I might die feeling. Epi#2 Given around 5 minutes after Epipen 1. Medics took me to the ER and  more rescue meds were given. I was admitted to the nuero trauma floor for 24 hrs and given meds and iv fluids. I got out the next afternoon. By the next day I was back in urgent care. They gave me meds and sent me home. By 9pm that night I was using epi#3 and going back to the ambulance. I have been to urgent care 2 times since for continued issues. I have zero appetite and my whole GI system hates me. I am alive and breathing but still feeling the impact of all of this.
Shingles R face, diagnosed by ER visit on 2/24/2021. rash began 2/20/2021.  pt called 911 and was transported by ambulance due to eye swollen shut from shingles.
Started with sweeping of hands, feeling hot and flushed, then redness of face. Extremely itchy. Fainted once arrived to ER.
I received the Moderna Bivalent booster for COVID-19 on 9/9/2022. On 11/26/2022, I had coughing, sore throat, diarrhea, and a little shortness of breath. I took some DAYQUIL, which reduced some symptoms, but not all. On 11/27/2022, I took a home antigen test and got a positive result. I got a prescription for PAXLOVID that day. I felt better in about two days and rebounded on day 5. I'm currently doing fine, though I still have a little bit of fatigue and cough.
Fatigue, headache, chills, fever, body aches, nausea, muscle pain
Breakthrough case admission after 2 vaccines Moderna 3/22/21 Lot# 007B21A;  Moderna 4/19/21 Lot# 043B21A
very flu like symptoms. severe body ache, chills, fatigue, nauseau, dizzy/cloudy head, NO fever. Lasted in the worst of it 9 days, now in the lingering 'long haul' stage. Treatment was ibuprofen and tylenol pm, and a lot of sleep/rest and exercise/fresh air when I could.
After receiving Shingrix vaccine, patient had arm pain, redness and swelling.  Has since seen her doctor and has muscle damage.  Was told by physician that it may be permanent damage
One later after vaccination got low fever, he didn't feel good, and got no energy. Also he was getting tender spots from the torso. Today has been three weeks, and he doesn't have fever but he still has the tender spots they rotate around his torso The family doctor said it may be shingles, but he has no rash, he also thinks it may be reaction to the vaccination. I talk to the RN in the Health Department, and she suggested to file this report.
Tinnitus worsened tremendously. Afraid to get second shot now. The tinnitus is intolerable.
Moderate-to-severe swelling of left arm on Day 2 followed by swelling and redness on Day 3. On Day2, fever, disseminated joint pain, fatigue. Swelling and redness still ongoing